July 24, 2014 1:53 PM ET

Biotechnology

Company Overview of Aileron Therapeutics, Inc.

Executive Profile

David G. Nathan M.D.

Member of the Scientific Advisory Board, Aileron Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. David G. Nathan, M.D. serves as the President Emeritus of Dana-Farber Cancer Institute, Inc. Dr. Nathan serves as a Professor of Medicine at Harvard Medical School. Dr. Nathan served as Physician-in-Chief of the Department of Medicine at Children's Hospital, Boston, and as President of the Dana-Farber Cancer Institute. From 1967 to 1984, he served as Chief of Hematology at Children's Hospital Boston (CHB), and Chief of Hematology and Oncology at CHB and DFCI. Dr. ...

Corporate Headquarters

281 Albany Street
Cambridge, Massachusetts 02139

United States

Phone: 617-995-0900
Fax: 617-995-2410

Board Members Memberships

Trustee
Director
Trustee

Education

MD 1955
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aileron Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.